Jinda Healthcare
行业洞察

Sample Approval for Mobility Aids: First Article vs. Approved Sample

Most mobility aid buyers already have a sample check routine in mind: unbox it, look at the finish, measure a few dimensions, push down on the frame. But ask which sample is the reference the bulk order will be judged against, and the answer often gets fuzzy. That is because there are two kinds of samples, and they do different jobs: the first article taken off a live production run, and the approved sample that locks in the agreed configuration. Use the wrong one as your baseline and the bulk shipment will not match.

Mobility aid specifications do not line up as neatly as standard hardware. Material, dimensions and configuration can shift with every order. However carefully you inspect a sample, if you have not sorted out whether it proves production conditions or proves final configuration, you will still struggle to pin down who is responsible when something drifts.

The first article: does the production setup hold

First-article approval checks whether the material, tooling, fixtures and process settings are on target when a batch actually starts running. The practice exists mainly for the factory's own benefit: the first pieces off the line are checked item by item against the standard, and only when the conditions are right does bulk production go ahead.

Its real value is that it surfaces whether this batch will differ from the last one. Many mobility aid problems, such as a wobbly fit after assembly, misaligned holes, or a frame that feels loose, are not caused by a single bad unit. They come from a change in production conditions: a different material lot, a worn mold, swapped fixture shims, a drifted setting. The first article is the gate that stops those changes before they reach the whole order.

For a buyer, whether a factory is willing to run a first article, report the results item by item, and stop to correct a deviation matters far more than how polished the showroom looks. What the showroom shows you is whether the product can be built. The first article tells you whether this batch will actually look like that.

The approved sample: what your order is supposed to be

The approved sample answers a different question: it fixes what this specific order will look like. A single category usually spans several configurations. Seats may come in a blow-molded version or a leather version, and frame colors, armrest styles and packaging methods can all vary. The approved sample settles each of these points one by one, and every later batch is made to match it.

So a sample is not something you just glance at. When you sign one off, it is worth putting a few things on paper: which characteristics fall within an acceptable range, which dimensions are hard limits, how much tolerance a critical dimension allows, and whether color and texture are judged against the physical sample or a color card. Once that list is written down, both sides are measuring with the same ruler.

There is one easily overlooked practice: keep two units of the approved sample, one at the factory and one with you. This is not fussiness, it is what turns the phrase we built it to this into something reproducible. The factory can compare against the physical piece before every production run, and if a question comes up at goods-in you are not arguing from photos and memory.

Use the two together and one comparison is enough

The two samples do not conflict. They are two gates in sequence: the approved sample defines what it should be, and the first article confirms whether this batch is really being built that way. Combining them before a bulk order is placed is actually more efficient than handling them apart.

The concrete move is to take the approved sample to where the bulk goods are being made and run one comparison. Against pieces produced from the same material lot and the same tooling, check whether dimensions fall inside tolerance, whether color is consistent, whether the clearance at joints has changed, and whether the packaging method has been altered. On a mobility aid, these details are usually what determines whether the end user can actually get along with it.

Doing this pays off directly in return rates. This batch is not the same as the last one is one of the most common complaints in mobility aids, and it is hard to catch. It does not show up in the finish the way a cosmetic defect does, and it does not produce the clear symptom of a functional failure. The user simply feels that it is not working the way it did before, and stops using it. Comparing the first article against the approved sample catches exactly this class of problem before the goods ship.

Three things a buyer can put in place now

First, ask which kind of sample you are holding. Is it a first article off the line, a sample made specifically for approval, or both in one? It may be the same object, but the label tells you what was actually verified.

Second, when the approved sample is signed off, put the critical items on paper: hard dimensions, tolerances, the color reference, the packaging method, the parts list. A verbal close enough carries no weight once the bulk goods arrive.

Third, compare one first article against the approved sample before bulk shipment and keep the record. It takes a single exercise, but it turns build it to this from a promise into a documented reference.

Mobility aid sourcing is not really a contest over who asks more questions. It comes down to who defines the right things clearly. First-article approval and the approved sample are the two moves that lock down production and configuration respectively. Sort out what each is for, and the sample you paid for stops being wasted effort.

Guangdong Jinda Healthcare Products Co., Ltd.


Guangdong Jinda Healthcare Products Co., Ltd.